This week brings some exciting figures. On Monday, Apple will present its financial results after the stock market closes ... Show more
Who will get the first psychedelic approved?: Today's biotech news examines Gilead's HIV prevention shot goes generic, Bright Minds' seizure drug ...
statnews.com/2026/11/03/biotech-news-who-will-get-the-first-psychedelic-approved/
Who will get the first psychedelic approved?
Pfizer beat earnings expectations and raised its full-year sales and profit outlook
qz.com/pfizer-earnings-beat-raises-full-year-outlook-110326
Pfizer beat earnings expectations and raised its full-year sales and ...
Pfizer dividend stock: Business stagnates - | Forecast still raised: The US pharmaceutical company has published its quarterly figures for the third quarter of ...
deraktionaer.de/artikel/pharma-biotech/dividenden-aktie-pfizer-geschaeft-stagniert-prognose-dennoch-erhoeht-20431644.html
Pfizer dividend stock: Business stagnates - | Forecast still raised
Jobs, Midterm Elections, Apple, Palantir, McDonald’s, Moderna, and More to Watch This Week
trib.al/ctSh4UZ
Jobs, Midterm Elections, Apple, Palantir, McDonald’s, Moderna ...
Looking for income? These dividend stocks have high yields that seem well supported.
trib.al/cCXVv6h
Looking for income? These dividend stocks have high yields that seem well ...
Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs: Seven of the best-selling drugs of 2026 from GEN's top 10, ranked by 2025 sales ...
qz.com/best-selling-drugs-2026-2025-sales
Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs
Meet the Corporations Funding Ramaswamy's Vicious Attack Ad on Acton: Corporate PACs for Bank of America, Deloitte, Kroger, Pfizer, Johnson & Johnson ...
commondreams.org/news/ramaswamy-attack-ad-corporations
Meet the Corporations Funding Ramaswamy's Vicious Attack Ad on Acton
OpinionCracks in the AI ​​hype: Why investors are fleeing tech stocks: An den Börsen findet eine Rotation statt: Die Anleger trennen sich von Halbleiterwerten und ...
diepresse.com/41385239/risse-im-ki-hype-warum-die-anleger-fluchtartig-technologieaktien
Cracks in the AI ​​hype: Why investors are fleeing tech stocks
These stocks and many others all hit new 52-week highs at some point today: $KO $MRNA $XOM $V $PFE $MA $KDP $BP $SHEL $EBAY $ETSY
Layoffs Tracker: Kroger, Pfizer, Netflix and Amazon Hit This Week: The latest cuts show that the recent layoffs are not confined to one corner of the economy.
newsweek.com/layoffs-october-kroger-pfizer-netflix-amazon-airtable-12564315
Layoffs Tracker: Kroger, Pfizer, Netflix and Amazon Hit This Week
Why Big Pharma is betting on longevity drugs: Inside the conference where FDA officials, Eli Lilly, Pfizer, and biotech leaders mapped out the future of ...
businessinsider.com/why-big-pharma-betting-longevity-drugs-2026-10
Why Big Pharma is betting on longevity drugs
Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study: Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved ...
investors.com/news/technology/vaxcyte-stock-pfizer-merck-pneumococcal-vaccine/
Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine ...
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck
investors.com/news/technology/summit-therapeutics-stock-astrazeneca-investment/
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal ...
Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi, sources say: Pfizer CEO Albert Bourla and Meta Platforms chief ​Mark Zuckerberg are the ...
reuters.com/world/china/pfizer-ceo-bourla-plans-attend-white-house-state-dinner-chinas-xi-source-says-2026-09-22/
Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi ...
Colombia Investment Portfolio of 176 Projects Presented in New York: The Colombia investment portfolio of 176 projects, valued at more than US$150 billion ...
riotimesonline.com/colombia-investment-portfolio-new-york-2026/
Colombia Investment Portfolio of 176 Projects Presented in New York
Panama Canal Investment Plan: US$8.5 Billion Pitched in New York: Mulino pitched a US$8.5 billion Panama Canal investment plan to Citi and 26 investors in New ...
riotimesonline.com/panama-canal-investment-mulino-new-york-citi-2026/
Panama Canal Investment Plan: US$8.5 Billion Pitched in New York
Pfizer depot suspended after Bengaluru fake drug bust; 16 licences cancelled: An investigation found that low-cost medications were allegedly refilled into new ...
indianexpress.com/article/cities/bangalore/bengaluru-pfizer-depot-suspended-fake-drug-bust-16-licences-cancelled-10887193/
Pfizer depot suspended after Bengaluru fake drug bust; 16 licences ...
Next shock for Novo Nordisk shareholders: This is why the stock is plummeting: Novo Nordisk lowers growth expectations and warns of patent expirations ...
boerse-online.de/nachrichten/aktien/naechster-schock-fuer-novo-nordisk-aktionaere-darum-rauscht-die-aktie-ab-20409207.html
Next shock for Novo Nordisk shareholders: This is why the stock is ...
Pfizer: Secret deal with Trump - | but at what price?: Pfizer has to partially pay higher foreign drug prices to the US Department of Health and Human Services ...
deraktionaer.de/artikel/aktien/pfizer-geheim-deal-mit-trump-aber-um-welchen-preis-20409166.html
Pfizer: Secret deal with Trump - | but at what price?
Big pharma exports from Ireland an impetus to euro zone growth: Euro zone economy expands more than initially thought after a sharp upward revision in Ireland
irishtimes.com/business/2026/09/08/big-pharma-exports-from-ireland-inject-life-into-euro-zone-growth/
Big pharma exports from Ireland an impetus to euro zone growth
Czechia spent CZK 19 billion on Covid vaccines, but only used half of them: The country has used fewer than half of the 41 million Covid vaccine doses bought ...
expats.cz/czech-news/article/czechia-spent-czk-19-billion-on-covid-vaccines-but-only-used-half-of-them
Czechia spent CZK 19 billion on Covid vaccines, but only used half of them
Insiders are now buying these stocks - | Buy signal?: Insider purchases of companies like Pfizer and Blackstone are considered a buy signal for investors ...
boerse-online.de/nachrichten/aktien/insider-schlagen-jetzt-bei-diesen-aktien-zu-kaufsignal-20406826.html
Insiders are now buying these stocks - | Buy signal?
Pfizer partner Valneva: Shares take off - | Tick vaccine on the verge of a breakthrough?
deraktionaer.de/artikel/pharma-biotech/pfizer-partner-valneva-aktie-hebt-ab-zeckenimpfstoff-vor-dem-durchbruch-20406785.html
Pfizer partner Valneva: Shares take off - | Tick vaccine on the verge of a ...
John Wilson on Why He Made a Documentary About Concrete: John Wilson ended his beloved HBO docuseries ‘How To’ and started making a movie about the terrors of ...
vulture.com/article/john-wilson-on-why-he-made-a-documentary-about-concrete.html
John Wilson on Why He Made a Documentary About Concrete
Insiders strike: These 5 stocks are being bought behind the scenes: Last week, insiders bought shares of Pfizer, TSMC, Tilray, Lumen, and Boston Scientific ...
boerse-online.de/nachrichten/aktien/insider-schlagen-zu-diese-5-aktien-werden-im-hintergrund-gekauft-20406443.html
Insiders strike: These 5 stocks are being bought behind the scenes
Pfizer Ducks Continued Covid Fallout As Hard-Fought Obesity Readout Looms: Pfizer beat second-quarter expectations Tuesday, offsetting a continued steep decline ...
investors.com/news/technology/pfizer-stock-pfizer-earnings-q2-2026/
Pfizer Ducks Continued Covid Fallout As Hard-Fought Obesity Readout Looms
Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more
statnews.com/pharmalot/2026/08/05/medicare-pilot-orphan-drugs-pfizer-cutbacks/
Pharmalittle: We’re reading about a Medicare pilot and orphan drugs ...
Small NZ drugmaker quietly outperforms global giants Pfizer and Merck: Business & investing: A small NZ pharma firm is beating global giants on per-employee ...
newsroom.co.nz/2026/08/03/small-nz-drugmaker-quietly-outperforms-global-giants-pfizer-and-merck/
Small NZ drugmaker quietly outperforms global giants Pfizer and Merck
Insider: Mega-merger between AstraZeneca and Bristol Myers under discussion: British company reportedly considering a $400 billion merger with Bristol Myers ...
sueddeutsche.de/wirtschaft/pharma-astra-zeneca-fusion-li.3525805
Insider: Mega-merger between AstraZeneca and Bristol Myers under ...
At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer: Positive data landed for treatments in multiple myeloma and non-small cell lung ...
statnews.com/2026/05/29/asco-news-day-1-multiple-myeloma-bristol-lung-cancer-pfizer/
At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung ...
Allogene CEO David Chang stepping down: Today's biotech news includes Pfizer investing billions to buy Chinese drugs, WHO mapping experimental response to ...
statnews.com/2026/05/29/biotech-news-allogene-ceo-david-chang-steps-down/
Allogene CEO David Chang stepping down
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion: Innovent Biologics rose as much as 10%, after entering a strategic global ...
cnbc.com/2026/05/29/innovent-shares-rise-10percent-after-pact-with-pfizer-of-up-to-10point5-billion.html
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10 ...
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise: The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise ...
investors.com/news/technology/pfizer-pneumococcal-vaccine-prevnar-merck-vaxcyte/
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise
An overview of this week's top and bottom performers in the DAX and S&P 500! 💡